erythrosine has been researched along with Flavivirus Infections in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brecher, M; Chen, H; Huang, R; Koetzner, CA; Kramer, LD; Li, H; Li, Z; Qin, CF; Sakamuru, S; Xia, M; Zhang, J; Zhang, QY; Zhou, J | 1 |
1 other study(ies) available for erythrosine and Flavivirus Infections
Article | Year |
---|---|
Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease.
Topics: Antiviral Agents; Cells, Cultured; Dose-Response Relationship, Drug; Erythrosine; Flavivirus; Flavivirus Infections; Gene Expression Regulation, Viral; Humans; Models, Molecular; Molecular Conformation; Protease Inhibitors; Protein Binding; RNA Helicases; Serine Endopeptidases; Structure-Activity Relationship; Viral Nonstructural Proteins | 2018 |